SlideShare a Scribd company logo
R0 VALUE & HERD IMMUNITY
(HERD EFFECT/ COMMUNITY IMMUNITY/
POPULATION IMMUNITY/ SOCIAL
IMMUNITY)
DR. BHOJ R SINGH, PRINCIPAL SCIENTIST (VM)
HEAD DIVISION OF EPIDEMIOLOGY
INDIAN VETERINARY RESEARCH INSTITUTE, IZATNAGAR-243122, BAREILLY, UP, INDIA.
TELEFAX +91-581-2302188
THE PROPORTION OF IMMUNE INDIVIDUALS IN A POPULATION
ABOVE WHICH A DISEASE MAY NO LONGER PERSIST IS THE
HERD IMMUNITY THRESHOLD.
R0 VALUES
The average number of secondary cases arising from an
average primary case in an entirely susceptible population.
The basic reproduction number (basic reproductive rate, basic
reproductive ratio R0) of a contagious disease is the number of
cases than a case of the disease generates (on an average) over
the course of its infectious period in a susceptible population.
FACTORS DETERMINING THE R0
 R0 will vary from agent to agent depending on the
infectiousness of the agent.
 R0 may also vary from population to population
depending on population density.
 Course of infectiousness of the disease. Incubation
period, latent periods and period of infectiousness).
 Mode of transmission and contagiousness.
FACTORS AFFECTING R0
It can be explained by the epidemiological triad
 Host Factor: Mixed Population, different age group of
animals, difference in nutritional status, inbred
population, parasitic load and mobility of host.
 Environment Factor: Seasonal Variation e.g., FMD
(autumn and spring) and Malaria (hot and humid
climate).
 Agent Factor: The agent may not spread at the same
rate in all the countries. Genetic changes in the host
factors like Genetic drift and genetic shift. Evolution of
new antigenic variant strains.
COURSE OF SOME INFECTIOUS
DISEASES IN DAYS
Infectious disease Incubation period Latent period Infectious period
Measles 8-13 6-9 6-7
Mumps 12-26 12-18 4-8
Pertussis 6-10 21-23 7-10
Rubella 14-21 7-14 11-12
Diphtheria 2-5 14-21 2-5
Chickenpox 13-17 8-12 10-11
Hepatitis B 30-80 13-17 19-22
Poliomyelitis 7-12 1-3 14-20
Influenza 1-3 1-3 1-3
Smallpox 10-15 8-11 2-3
Scarlet fever 2-3 1-2 14-21
Infectious disease Host R0
Measles Humans (UK) 12-18
Pertussis (whooping cough) Humans (UK) 12-18
Chickenpox (varicella) Humans (UK) 10-12 (16-18 in India)
Rubella Humans (UK) 5-7
Smallpox Humans 3.5-7
Feline immunodeficiency virus
(FIV) Domestic Cats 1.1-1.5
Rabies Dogs (Kenya) 2.44
Phocine distemper Seals 2-3
Tuberculosis Cattle 2.6
Influenza (Pandemic) Humans 2-4
Foot-and-mouth disease Livestock farms (UK) 3.5-4.5
Mumps Humans 4-12
Poliomyelitis (polio) Humans 5
HIV/AIDS Hetro 2-5
HIV Male homosexuals UK 4
HIV Female prostitutes in Kenya 11
Malaria Humans ≈ 100
SARS Human 2-5
IBR Cattle (UK) 7
TB Cattle 2.6
R0 of Some Diseases
R0 IS AFFECTED BY MODE OF
TRANSMISSION
Disease Transmission R0
Measles Airborne 12–18
Pertussis Airborne droplet 12–17
Diphtheria Saliva 6–7
Smallpox Social contact 5–7
Polio Fecal-oral route 5–7
Rubella Airborne droplet 5–7
Mumps Airborne droplet 4–7
HIV/AIDS Sexual contact 2–5
SARS Airborne droplet 2–5
Influenza (1918
pandemic strain)
Airborne droplet 2–3
CALCULATION OF R0
 R0= β/ γ
 γ= 1/ average infectious period
 β= Transmission rate (Number contacts by infective case in
defined time, contact rate)
 If susceptible fraction of a population is >1/R0 then only
disease can progress. We can get is by vaccination, preventive
therapy or control measures.
 When initial fraction of susceptible population is less than γ/β
or 1/R0 then infection can not progress and dies out, it is
called the threshold fraction.
 R0 is also defined as inverse of relative removal rate (the
already got infected during the period).
 1- 1/R0 is also defined as fraction of the population to be
vaccinated for getting herd immunity.
HOW TO REDUCE R0 VALUE?
R0 can be reduced through intervention at any point in the
transmission cycle by the following methods:
 Reducing or eliminating the shedding of the agent by the
infected host. e.g., by antibiotics and segregation and
quarantine.
 Reducing the duration of environmental survival of the agent.
e.g., sunlight, fumigation, aeration etc.
 Reducing or eliminating vehicle contamination and fomite
transmission.
 Controlling the Vector Population for biological transmission.
 Reducing the exposure of susceptible host. e.g., density
reduction, provision of protective gears as masks, goggles,
aprons, gloves, gumboots etc.
 Increasing the resistance of susceptible host by vaccination,
passive immunization etc.
IMPORTANCE OF RO
 For an infectious disease with average infectious
period 1/γ and transmission rate β, Ro = β/γ:
 For a closed population, an infectious disease can only
invade if there is a threshold fraction of susceptible
individuals greater than 1/Ro .
 If R0 is 2.5 then 1/R0 is 0.4, i.e., for control of the
disease less than 0.4 fraction of the population be
susceptible or more than 60% be non-susceptible or
immune.
 Vaccination policy: if proportion of susceptible
individuals is reduced to below 1/Ro the disease can be
eradicated.
LIMITATIONS
 When calculated from mathematical models, particularly using
ordinary differential equations, R0 is, in fact, simply a
threshold, not the average number of secondary infections.
 There are many methods used to derive such a threshold from a
mathematical model, but many of them often give an
hypothetical value sometimes far away from the the true value
of R0. This is particularly problematic if there are intermediate
vectors between hosts, such as malaria.
 Methods include the survival function, rearranging the
largest value from the Jacobian matrix, the next-generation
method, calculations from the intrinsic growth rate, existence of
the endemic equilibrium, the number of susceptibles at the
endemic equilibrium, the average age of infection and the final
size equation.
 Few of these methods agree with one another, even when
starting with the same system of differential equations. Even
fewer actually calculate the average number of secondary
infections. Since R0 is rarely observed in the field and is usually
calculated via a mathematical model, this severely limits its
usefulness
HERD IMMUNITY
 The term herd immunity was first used in 1923.
 It was an integral part During the Small Pox eradication in the
1960s and 1970s.
 The practice of Ring Vaccination, of which herd immunity is
integral to, began as a way to immunize every person in a
"ring" around an infected individual to prevent outbreaks from
spreading.
 Vaccination controversies and opposing of vaccination are
mainly due to failed herd immunity, either it was not be
established or disappeared in certain communities, allowing
preventable diseases to persist in or return to these
communities.
 Topley, W. W. C.; Wilson, G. S. (May 1923). "The Spread of Bacterial Infection. The Problem of Herd-
Immunity". The Journal of Hygiene (London). 21 (3): 243–
249. PMC 2167341 . PMID 20474777. doi:10.1017/s0022172400031478.
 Strassburg, M. A. (1982). "The global eradication of smallpox". American journal of infection control. 10 (2): 53–
9. PMID 7044193. doi:10.1016/0196-6553(82)90003-7.
DEFINITION OF HERD IMMUNITY
As per John TJ, Samuel R. European Journal of Epidemiology
2000;16, Herd Immunity can be defined as follows:
1. The resistance of a group for attack by a disease because of the
immunity of a large proportion of the members and the
consequent lessening of the likelihood of an affected individual
coming into contact with a susceptible individual.
2. The prevalence of immunity in a population above which it
becomes difficult for the organism to circulate and reach new
susceptible is called herd immunity.
3. It is well known that not everyone in a population needs to be
immunised to eliminate disease.
HERD IMMUNITY
 The indirect protection from infection of
susceptible livestock in a herd, and the
protection of the herd as a whole, which is
brought about by the presence of immune
individuals.
 The number of individuals in a population
(herd) who are (relatively) immune to
infection with an infectious agent may
depend on the proportion who have
previously been infected with the agent
and the proportion who have been
vaccinated with an efficacious vaccine.
 A measure of the level of population-immunity or herd-
immunity is the proportion who are thus immune from further
infection.
 For many infections, the level of herd immunity may have an
effect on the transmission of the infection within the population
and, in particular, may affect the risk of an uninfected becoming
infected.
 For such infections, increasing the level of herd immunity will
decrease the risk of an uninfected person becoming infected.
 If the herd effect reduces the risk of infection among the
uninfected sufficiently then the infection may no longer be
sustainable within the population and the infection may be
eliminated.
 This concept is important in disease elimination or eradication
programmes. It means, for example, that elimination can be
achieved without necessarily vaccinating the entire population.
TYPES OF HERD IMMUNITY
Innate (Inherent) Herd Immunity: It is
genetically determined physiological changes with respect to
antibody production or other defence mechanism in a herd. It
does not depend on the previous exposure of herd with
infection or it may arise in a herd through prolonged exposure
to an infection or natural selection.
 Some population of domestic fowl
have innate resistance to pullorum
disease due to an inherited difference
in lymphocyte numbers immediately
after hatching.(Robert & Card,1926)
 Inheritance of resistance to influenza
virus in mice is probably due to a
single dominant autosomal allele.
(Lindermann, 1964)
 Cameroon et al have shown that
resistance to brucellosis in swine may
be genetically determined.
Acquired Herd Immunity: It is a type of herd
immunity where a sufficient number of its members have
actually been exposed naturally or artificially to infectious
agents during their lifespan.
 This kind of exposure may be made very early in life.
 Polio in paralytic form are rare in countries with poor hygiene
and sanitation where exposure to the virus occurs in early part
of life but in countries where the hygiene is better and exposure
is delayed till school age then paralytic manifestations are
higher.
ADVANTAGES OF HERD IMMUNITY
 Potential for infection elimination.
 Reduced risk of infection for those refusing vaccination (“free
riders”).
 Vaccination against sexually transmitted diseases (STIs)
targeted at one sex result in significant declines in sexual
disease in both sexes.
 Reduced risk of infection for those for whom vaccination is
contraindicated (e.g., immune-suppressed) or who cannot be
vaccinated e.g., cancer patients, too young animals and
pregnant animals.
 Prioritization of vaccination towards target groups or High
Risk groups in the community may lead to protection of the
whole community e.g. prioritization of vaccinating children
against pneumococcus and rotavirus, school-age children for
seasonal flu immunization reduces of the disease burden in
the whole community.
Limitations
 Herd immunity generally applies only to diseases that are contagious. It
does not apply to diseases such as tetanus, botulism food borne infections
and intoxications.
 Raise the average age of infection among those who are infected.
 Particular problem for those infections where the severity of infection
increases with age (e.g. polio, rubella, varicella, measles, hepatitis A).
 It is not a permanent attribute, depending on the duration of the immunity
conferred after vaccination the structure of herd for susceptible versus
immune rapidly changes.
 Herd immunity might be associated with emergence of variants of
pathogens more dangerous than the existent due to Evolution Pressure on
the pathogen or Selection Pressure on the antigen variant.
 Herd immunity may lead to antigenic variation among pathogens at much
faster rate than it would have been in the absence of herd immunity.
Leading to Serotype Replacement.
 Herd immunity not work for many of the infectious diseases like Tetanus,
Botulism, and similar toxico-infections.
BACTERIAL DISEASES OF LIVESTOCK
Sl.
No
Name of the
Disease
Host Range Type of Vaccine
Used
Duration of
Immunity
1 Haemorrhagic
Septicemia
Cattle, Sheep & Goat,
Pig
Inactivated alum
adjuvant vaccine
6 months
2 Black Quarter Cattle, Sheep & Goat Inactivated alum
adjuvant vaccine
6 months
3 Anthrax Cattle, Sheep & Goat Sterne-avirulent spore
vaccine
1 year
4 Brucellosis Cattle, Sheep & Goat Live freeze dried
vaccine
Life Long
5 Enterotoxemia Sheep Inactivated alum
adjuvant vaccine
6 months
6 Leptospirosis Canine Killed Mixed Vaccine 1 year
DISEASE ELIMINATION & HERD
IMMUNITY
 If the herd effect reduces the risk of infection among the
uninfected sufficiently then the infection may no longer be
sustainable within the population and the infection may be
eliminated.
 The “effective reproduction number” (R) has to be reduced
below 1.
 If a proportion (P) of the population are immune then R = (1- P)
R0
So, to get R down to about 1, P must be more than 1-1/ R0.
Thus if R0 = 5 then vaccine coverage will have to be in excess of
80%.
QUIZ
 What are the factors affecting reproduction ratio (R0
) of a disease?
 Give R0 values for important animal diseases.
 How is associated with herd immunity?
 Give herd immunity values required for prevention
of FMD, HS, BQ, Enterotoxemia, Goat Pox, Sheep
Pox, PPR, Brucellosis, Classical swine fever.
 What are different types of herd immunity in
animals?
 An useful link
https://www.historyofvaccines.org/content/herd-
immunity-0

More Related Content

What's hot

One Health: Concept and applications
One Health: Concept and applicationsOne Health: Concept and applications
One Health: Concept and applications
ILRI
 
One health
One healthOne health
One health
Reena Titoria
 
Outbreak investigation
Outbreak investigationOutbreak investigation
Outbreak investigation
Amandeep Kaur
 
Epidemiology an overview
Epidemiology an overviewEpidemiology an overview
Epidemiology an overview
Bhoj Raj Singh
 
Multifactorial causation of disease
Multifactorial causation of diseaseMultifactorial causation of disease
Multifactorial causation of disease
mayfair one
 
Rate, ratio, proportion
Rate, ratio, proportionRate, ratio, proportion
Rate, ratio, proportion
Dr Lipilekha Patnaik
 
Secondary attack rates
Secondary attack ratesSecondary attack rates
Secondary attack rates
Aswathi Krishna
 
Disease surveillance
Disease surveillanceDisease surveillance
Disease surveillance
BaylorWilliams2
 
Public Health Questions and Answers for Students
Public Health Questions and Answers for StudentsPublic Health Questions and Answers for Students
Public Health Questions and Answers for Students
Nayyar Kazmi
 
An Introduction to Infectious Disease Modeling
An Introduction to Infectious Disease ModelingAn Introduction to Infectious Disease Modeling
An Introduction to Infectious Disease Modeling
InsideScientific
 
Epidemiologic transition
Epidemiologic transitionEpidemiologic transition
Epidemiologic transition
Dr. Animesh Gupta
 
Standardization of rates
Standardization of ratesStandardization of rates
Standardization of rates
Halyna Lugova
 
Basics of epidemiology
Basics of epidemiologyBasics of epidemiology
Basics of epidemiology
Dipayan Banerjee
 
Infectious Disease Epidemiology
Infectious Disease EpidemiologyInfectious Disease Epidemiology
Infectious Disease Epidemiology
Arvind Kushwaha
 
Epidemic Curve
Epidemic CurveEpidemic Curve
Epidemic Curve
Jen-Hsiang Chuang
 
Public health surveillance
Public health surveillancePublic health surveillance
Public health surveillance
Dr Khyati Boriya -BDS (MHA)
 
Epidemic investigation
Epidemic investigationEpidemic investigation
Epidemic investigation
Dr Lipilekha Patnaik
 
Introduction to epidemiology
Introduction to epidemiologyIntroduction to epidemiology
Introduction to epidemiology
Dr Lipilekha Patnaik
 
Burden of Disease Analysis
Burden of Disease AnalysisBurden of Disease Analysis
Burden of Disease Analysis
sourav goswami
 
Disease screening
Disease screeningDisease screening
Disease screening
Amandeep Kaur
 

What's hot (20)

One Health: Concept and applications
One Health: Concept and applicationsOne Health: Concept and applications
One Health: Concept and applications
 
One health
One healthOne health
One health
 
Outbreak investigation
Outbreak investigationOutbreak investigation
Outbreak investigation
 
Epidemiology an overview
Epidemiology an overviewEpidemiology an overview
Epidemiology an overview
 
Multifactorial causation of disease
Multifactorial causation of diseaseMultifactorial causation of disease
Multifactorial causation of disease
 
Rate, ratio, proportion
Rate, ratio, proportionRate, ratio, proportion
Rate, ratio, proportion
 
Secondary attack rates
Secondary attack ratesSecondary attack rates
Secondary attack rates
 
Disease surveillance
Disease surveillanceDisease surveillance
Disease surveillance
 
Public Health Questions and Answers for Students
Public Health Questions and Answers for StudentsPublic Health Questions and Answers for Students
Public Health Questions and Answers for Students
 
An Introduction to Infectious Disease Modeling
An Introduction to Infectious Disease ModelingAn Introduction to Infectious Disease Modeling
An Introduction to Infectious Disease Modeling
 
Epidemiologic transition
Epidemiologic transitionEpidemiologic transition
Epidemiologic transition
 
Standardization of rates
Standardization of ratesStandardization of rates
Standardization of rates
 
Basics of epidemiology
Basics of epidemiologyBasics of epidemiology
Basics of epidemiology
 
Infectious Disease Epidemiology
Infectious Disease EpidemiologyInfectious Disease Epidemiology
Infectious Disease Epidemiology
 
Epidemic Curve
Epidemic CurveEpidemic Curve
Epidemic Curve
 
Public health surveillance
Public health surveillancePublic health surveillance
Public health surveillance
 
Epidemic investigation
Epidemic investigationEpidemic investigation
Epidemic investigation
 
Introduction to epidemiology
Introduction to epidemiologyIntroduction to epidemiology
Introduction to epidemiology
 
Burden of Disease Analysis
Burden of Disease AnalysisBurden of Disease Analysis
Burden of Disease Analysis
 
Disease screening
Disease screeningDisease screening
Disease screening
 

Similar to R0 Value & Herd Immunity

Epidemiology and vaccines
Epidemiology and vaccinesEpidemiology and vaccines
Epidemiology and vaccines
Bhoj Raj Singh
 
Understanding Herd immunity
Understanding Herd immunityUnderstanding Herd immunity
Understanding Herd immunity
dipesh125
 
Peste des-ruminants-is-a-rinderpest.doc pdf
Peste des-ruminants-is-a-rinderpest.doc pdfPeste des-ruminants-is-a-rinderpest.doc pdf
Peste des-ruminants-is-a-rinderpest.doc pdf
Gudyne Wafubwa
 
Vaccination or herd immunity?
Vaccination or herd immunity?Vaccination or herd immunity?
Vaccination or herd immunity?
DebjeetNath
 
Herd immunity
Herd immunityHerd immunity
Herd immunity
Archit Khardenavis
 
Emerging infectious diseases paper 203
Emerging infectious diseases  paper 203Emerging infectious diseases  paper 203
Emerging infectious diseases paper 203
karishma purkayastha
 
Infection and Disease 2021-22.pptx
Infection and Disease 2021-22.pptxInfection and Disease 2021-22.pptx
Infection and Disease 2021-22.pptx
jelikov
 
State two factors that have contributed to the development of emergi.pdf
State two factors that have contributed to the development of emergi.pdfState two factors that have contributed to the development of emergi.pdf
State two factors that have contributed to the development of emergi.pdf
eyevisioncare1
 
Illustrative Review on Rotavirus Vaccines
Illustrative Review on Rotavirus VaccinesIllustrative Review on Rotavirus Vaccines
Illustrative Review on Rotavirus Vaccines
ijtsrd
 
Martin Chang, MBBE final report, 2012_08_21
Martin Chang, MBBE final report, 2012_08_21Martin Chang, MBBE final report, 2012_08_21
Martin Chang, MBBE final report, 2012_08_21
Martin Chang
 
Epidemiological definitions
Epidemiological definitionsEpidemiological definitions
Epidemiological definitions
Dr. Saurabh Agrawal
 
Herd immunity final4
Herd immunity final4Herd immunity final4
Herd immunity final4
Hari Dev
 
DjaniDylan_Bluetongue
DjaniDylan_BluetongueDjaniDylan_Bluetongue
DjaniDylan_Bluetongue
Dylan Djani
 
Rabies
RabiesRabies
Surface infection
Surface infectionSurface infection
Surface infection
tulu2015
 
Maghaleh viruse
Maghaleh viruseMaghaleh viruse
Maghaleh viruse
zaynab seyedkhan
 
Infectious Disease
Infectious DiseaseInfectious Disease
Infectious Disease
Deep Deep
 
Measure of disease_occurence
Measure of disease_occurenceMeasure of disease_occurence
Measure of disease_occurence
ismailzai
 
Measure of disease_occurence (2)
Measure of disease_occurence (2)Measure of disease_occurence (2)
Measure of disease_occurence (2)
ismailzai
 
epidofmeasles-180920162327.pdf
epidofmeasles-180920162327.pdfepidofmeasles-180920162327.pdf
epidofmeasles-180920162327.pdf
Soujannya Kundu Chowdhury
 

Similar to R0 Value & Herd Immunity (20)

Epidemiology and vaccines
Epidemiology and vaccinesEpidemiology and vaccines
Epidemiology and vaccines
 
Understanding Herd immunity
Understanding Herd immunityUnderstanding Herd immunity
Understanding Herd immunity
 
Peste des-ruminants-is-a-rinderpest.doc pdf
Peste des-ruminants-is-a-rinderpest.doc pdfPeste des-ruminants-is-a-rinderpest.doc pdf
Peste des-ruminants-is-a-rinderpest.doc pdf
 
Vaccination or herd immunity?
Vaccination or herd immunity?Vaccination or herd immunity?
Vaccination or herd immunity?
 
Herd immunity
Herd immunityHerd immunity
Herd immunity
 
Emerging infectious diseases paper 203
Emerging infectious diseases  paper 203Emerging infectious diseases  paper 203
Emerging infectious diseases paper 203
 
Infection and Disease 2021-22.pptx
Infection and Disease 2021-22.pptxInfection and Disease 2021-22.pptx
Infection and Disease 2021-22.pptx
 
State two factors that have contributed to the development of emergi.pdf
State two factors that have contributed to the development of emergi.pdfState two factors that have contributed to the development of emergi.pdf
State two factors that have contributed to the development of emergi.pdf
 
Illustrative Review on Rotavirus Vaccines
Illustrative Review on Rotavirus VaccinesIllustrative Review on Rotavirus Vaccines
Illustrative Review on Rotavirus Vaccines
 
Martin Chang, MBBE final report, 2012_08_21
Martin Chang, MBBE final report, 2012_08_21Martin Chang, MBBE final report, 2012_08_21
Martin Chang, MBBE final report, 2012_08_21
 
Epidemiological definitions
Epidemiological definitionsEpidemiological definitions
Epidemiological definitions
 
Herd immunity final4
Herd immunity final4Herd immunity final4
Herd immunity final4
 
DjaniDylan_Bluetongue
DjaniDylan_BluetongueDjaniDylan_Bluetongue
DjaniDylan_Bluetongue
 
Rabies
RabiesRabies
Rabies
 
Surface infection
Surface infectionSurface infection
Surface infection
 
Maghaleh viruse
Maghaleh viruseMaghaleh viruse
Maghaleh viruse
 
Infectious Disease
Infectious DiseaseInfectious Disease
Infectious Disease
 
Measure of disease_occurence
Measure of disease_occurenceMeasure of disease_occurence
Measure of disease_occurence
 
Measure of disease_occurence (2)
Measure of disease_occurence (2)Measure of disease_occurence (2)
Measure of disease_occurence (2)
 
epidofmeasles-180920162327.pdf
epidofmeasles-180920162327.pdfepidofmeasles-180920162327.pdf
epidofmeasles-180920162327.pdf
 

More from Bhoj Raj Singh

Issues in Veterinary Disease Diagnosis.pptx
Issues in Veterinary Disease Diagnosis.pptxIssues in Veterinary Disease Diagnosis.pptx
Issues in Veterinary Disease Diagnosis.pptx
Bhoj Raj Singh
 
Epidemiological Approaches for Evaluation of diagnostic tests.pptx
Epidemiological Approaches for Evaluation of diagnostic tests.pptxEpidemiological Approaches for Evaluation of diagnostic tests.pptx
Epidemiological Approaches for Evaluation of diagnostic tests.pptx
Bhoj Raj Singh
 
Types of Trials in Medicine, vaccine efficacy or effectiveness trials and rel...
Types of Trials in Medicine, vaccine efficacy or effectiveness trials and rel...Types of Trials in Medicine, vaccine efficacy or effectiveness trials and rel...
Types of Trials in Medicine, vaccine efficacy or effectiveness trials and rel...
Bhoj Raj Singh
 
Detection and Characterization of Pathotypes, Serotypes, Biotypes, Phenotypes...
Detection and Characterization of Pathotypes, Serotypes, Biotypes, Phenotypes...Detection and Characterization of Pathotypes, Serotypes, Biotypes, Phenotypes...
Detection and Characterization of Pathotypes, Serotypes, Biotypes, Phenotypes...
Bhoj Raj Singh
 
Epidemiology of antigenic, genetic and biological diversity amongst pathogens...
Epidemiology of antigenic, genetic and biological diversity amongst pathogens...Epidemiology of antigenic, genetic and biological diversity amongst pathogens...
Epidemiology of antigenic, genetic and biological diversity amongst pathogens...
Bhoj Raj Singh
 
Differentiation of field isolates (wild) from vaccine strains (Marker, DIVA &...
Differentiation of field isolates (wild) from vaccine strains (Marker, DIVA &...Differentiation of field isolates (wild) from vaccine strains (Marker, DIVA &...
Differentiation of field isolates (wild) from vaccine strains (Marker, DIVA &...
Bhoj Raj Singh
 
Lumpy skin disease (LSD) Globally and in India.pptx
Lumpy skin disease (LSD) Globally and in India.pptxLumpy skin disease (LSD) Globally and in India.pptx
Lumpy skin disease (LSD) Globally and in India.pptx
Bhoj Raj Singh
 
Molecular determinants of pathogenicity and virulence among pathogens.pptx
Molecular determinants of pathogenicity and virulence among pathogens.pptxMolecular determinants of pathogenicity and virulence among pathogens.pptx
Molecular determinants of pathogenicity and virulence among pathogens.pptx
Bhoj Raj Singh
 
Molecular epidemiology and Disease causation.pptx
Molecular epidemiology and Disease causation.pptxMolecular epidemiology and Disease causation.pptx
Molecular epidemiology and Disease causation.pptx
Bhoj Raj Singh
 
My research proposals, to porotect holy cow, rejected by the ICAR-IVRI in the...
My research proposals, to porotect holy cow, rejected by the ICAR-IVRI in the...My research proposals, to porotect holy cow, rejected by the ICAR-IVRI in the...
My research proposals, to porotect holy cow, rejected by the ICAR-IVRI in the...
Bhoj Raj Singh
 
Animal Disease Control and Antimicrobial Resistance-A Message to Veterinary S...
Animal Disease Control and Antimicrobial Resistance-A Message to Veterinary S...Animal Disease Control and Antimicrobial Resistance-A Message to Veterinary S...
Animal Disease Control and Antimicrobial Resistance-A Message to Veterinary S...
Bhoj Raj Singh
 
Causes of Disease and Preserving Health in Different systems of Medicine.pptx
Causes of Disease and Preserving Health in Different systems of Medicine.pptxCauses of Disease and Preserving Health in Different systems of Medicine.pptx
Causes of Disease and Preserving Health in Different systems of Medicine.pptx
Bhoj Raj Singh
 
AMR challenges in human from animal foods- Facts and Myths.pptx
AMR challenges in human from animal foods- Facts and Myths.pptxAMR challenges in human from animal foods- Facts and Myths.pptx
AMR challenges in human from animal foods- Facts and Myths.pptx
Bhoj Raj Singh
 
Herbal Antimicrobials to Counter AMR.pptx
Herbal Antimicrobials to Counter AMR.pptxHerbal Antimicrobials to Counter AMR.pptx
Herbal Antimicrobials to Counter AMR.pptx
Bhoj Raj Singh
 
Epidemiological characterisation of Burkholderia cepacia complex (Bcc) from c...
Epidemiological characterisation of Burkholderia cepacia complex (Bcc) from c...Epidemiological characterisation of Burkholderia cepacia complex (Bcc) from c...
Epidemiological characterisation of Burkholderia cepacia complex (Bcc) from c...
Bhoj Raj Singh
 
Veterinary Vaccines.pptx
Veterinary Vaccines.pptxVeterinary Vaccines.pptx
Veterinary Vaccines.pptx
Bhoj Raj Singh
 
Major flaws in Animal Disease Control Leading to Partial Success or Failure.pptx
Major flaws in Animal Disease Control Leading to Partial Success or Failure.pptxMajor flaws in Animal Disease Control Leading to Partial Success or Failure.pptx
Major flaws in Animal Disease Control Leading to Partial Success or Failure.pptx
Bhoj Raj Singh
 
Animal Disease Control Programs in India.ppt
Animal Disease Control Programs in India.pptAnimal Disease Control Programs in India.ppt
Animal Disease Control Programs in India.ppt
Bhoj Raj Singh
 
Control and Eradication of Animal diseases.pptx
Control and Eradication of Animal diseases.pptxControl and Eradication of Animal diseases.pptx
Control and Eradication of Animal diseases.pptx
Bhoj Raj Singh
 
Clinical Microbiology in Laboratory
Clinical Microbiology in LaboratoryClinical Microbiology in Laboratory
Clinical Microbiology in Laboratory
Bhoj Raj Singh
 

More from Bhoj Raj Singh (20)

Issues in Veterinary Disease Diagnosis.pptx
Issues in Veterinary Disease Diagnosis.pptxIssues in Veterinary Disease Diagnosis.pptx
Issues in Veterinary Disease Diagnosis.pptx
 
Epidemiological Approaches for Evaluation of diagnostic tests.pptx
Epidemiological Approaches for Evaluation of diagnostic tests.pptxEpidemiological Approaches for Evaluation of diagnostic tests.pptx
Epidemiological Approaches for Evaluation of diagnostic tests.pptx
 
Types of Trials in Medicine, vaccine efficacy or effectiveness trials and rel...
Types of Trials in Medicine, vaccine efficacy or effectiveness trials and rel...Types of Trials in Medicine, vaccine efficacy or effectiveness trials and rel...
Types of Trials in Medicine, vaccine efficacy or effectiveness trials and rel...
 
Detection and Characterization of Pathotypes, Serotypes, Biotypes, Phenotypes...
Detection and Characterization of Pathotypes, Serotypes, Biotypes, Phenotypes...Detection and Characterization of Pathotypes, Serotypes, Biotypes, Phenotypes...
Detection and Characterization of Pathotypes, Serotypes, Biotypes, Phenotypes...
 
Epidemiology of antigenic, genetic and biological diversity amongst pathogens...
Epidemiology of antigenic, genetic and biological diversity amongst pathogens...Epidemiology of antigenic, genetic and biological diversity amongst pathogens...
Epidemiology of antigenic, genetic and biological diversity amongst pathogens...
 
Differentiation of field isolates (wild) from vaccine strains (Marker, DIVA &...
Differentiation of field isolates (wild) from vaccine strains (Marker, DIVA &...Differentiation of field isolates (wild) from vaccine strains (Marker, DIVA &...
Differentiation of field isolates (wild) from vaccine strains (Marker, DIVA &...
 
Lumpy skin disease (LSD) Globally and in India.pptx
Lumpy skin disease (LSD) Globally and in India.pptxLumpy skin disease (LSD) Globally and in India.pptx
Lumpy skin disease (LSD) Globally and in India.pptx
 
Molecular determinants of pathogenicity and virulence among pathogens.pptx
Molecular determinants of pathogenicity and virulence among pathogens.pptxMolecular determinants of pathogenicity and virulence among pathogens.pptx
Molecular determinants of pathogenicity and virulence among pathogens.pptx
 
Molecular epidemiology and Disease causation.pptx
Molecular epidemiology and Disease causation.pptxMolecular epidemiology and Disease causation.pptx
Molecular epidemiology and Disease causation.pptx
 
My research proposals, to porotect holy cow, rejected by the ICAR-IVRI in the...
My research proposals, to porotect holy cow, rejected by the ICAR-IVRI in the...My research proposals, to porotect holy cow, rejected by the ICAR-IVRI in the...
My research proposals, to porotect holy cow, rejected by the ICAR-IVRI in the...
 
Animal Disease Control and Antimicrobial Resistance-A Message to Veterinary S...
Animal Disease Control and Antimicrobial Resistance-A Message to Veterinary S...Animal Disease Control and Antimicrobial Resistance-A Message to Veterinary S...
Animal Disease Control and Antimicrobial Resistance-A Message to Veterinary S...
 
Causes of Disease and Preserving Health in Different systems of Medicine.pptx
Causes of Disease and Preserving Health in Different systems of Medicine.pptxCauses of Disease and Preserving Health in Different systems of Medicine.pptx
Causes of Disease and Preserving Health in Different systems of Medicine.pptx
 
AMR challenges in human from animal foods- Facts and Myths.pptx
AMR challenges in human from animal foods- Facts and Myths.pptxAMR challenges in human from animal foods- Facts and Myths.pptx
AMR challenges in human from animal foods- Facts and Myths.pptx
 
Herbal Antimicrobials to Counter AMR.pptx
Herbal Antimicrobials to Counter AMR.pptxHerbal Antimicrobials to Counter AMR.pptx
Herbal Antimicrobials to Counter AMR.pptx
 
Epidemiological characterisation of Burkholderia cepacia complex (Bcc) from c...
Epidemiological characterisation of Burkholderia cepacia complex (Bcc) from c...Epidemiological characterisation of Burkholderia cepacia complex (Bcc) from c...
Epidemiological characterisation of Burkholderia cepacia complex (Bcc) from c...
 
Veterinary Vaccines.pptx
Veterinary Vaccines.pptxVeterinary Vaccines.pptx
Veterinary Vaccines.pptx
 
Major flaws in Animal Disease Control Leading to Partial Success or Failure.pptx
Major flaws in Animal Disease Control Leading to Partial Success or Failure.pptxMajor flaws in Animal Disease Control Leading to Partial Success or Failure.pptx
Major flaws in Animal Disease Control Leading to Partial Success or Failure.pptx
 
Animal Disease Control Programs in India.ppt
Animal Disease Control Programs in India.pptAnimal Disease Control Programs in India.ppt
Animal Disease Control Programs in India.ppt
 
Control and Eradication of Animal diseases.pptx
Control and Eradication of Animal diseases.pptxControl and Eradication of Animal diseases.pptx
Control and Eradication of Animal diseases.pptx
 
Clinical Microbiology in Laboratory
Clinical Microbiology in LaboratoryClinical Microbiology in Laboratory
Clinical Microbiology in Laboratory
 

Recently uploaded

NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
Dr. Ahana Haroon
 
Introduction to British pharmacopeia.pptx
Introduction to British pharmacopeia.pptxIntroduction to British pharmacopeia.pptx
Introduction to British pharmacopeia.pptx
taiba qazi
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
Torstein Dalen-Lorentsen
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Jim Jacob Roy
 
All about shoulder Joint ..
All about shoulder Joint .. All about shoulder Joint ..
All about shoulder Joint ..
Aswan University Hospital
 
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticalsacne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
MuskanShingari
 
Know the difference between Endodontics and Orthodontics.
Know the difference between Endodontics and Orthodontics.Know the difference between Endodontics and Orthodontics.
Know the difference between Endodontics and Orthodontics.
Gokuldas Hospital
 
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...
Université de Montréal
 
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Call Girls In Mumbai +91-7426014248 High Profile Call Girl MumbaiCall Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Mobile Problem
 
Giloy in Ayurveda - Classical Categorization and Synonyms
Giloy in Ayurveda - Classical Categorization and SynonymsGiloy in Ayurveda - Classical Categorization and Synonyms
Giloy in Ayurveda - Classical Categorization and Synonyms
Planet Ayurveda
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
Dr. Nikhilkumar Sakle
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
NX Healthcare
 
RESPIRATORY DISEASES by bhavya kelavadiya
RESPIRATORY DISEASES by bhavya kelavadiyaRESPIRATORY DISEASES by bhavya kelavadiya
RESPIRATORY DISEASES by bhavya kelavadiya
Bhavyakelawadiya
 
Nutritional deficiency disorder in Child
Nutritional deficiency disorder in ChildNutritional deficiency disorder in Child
Nutritional deficiency disorder in Child
Bhavyakelawadiya
 
biomechanics of running. Dr.dhwani.pptx
biomechanics of running.   Dr.dhwani.pptxbiomechanics of running.   Dr.dhwani.pptx
biomechanics of running. Dr.dhwani.pptx
Dr. Dhwani kawedia
 
pharmacy exam preparation for undergradute students.pptx
pharmacy exam preparation for undergradute students.pptxpharmacy exam preparation for undergradute students.pptx
pharmacy exam preparation for undergradute students.pptx
AdugnaWari
 
Local anesthetics 2024/ Medicinal Chemistry pdf
Local anesthetics 2024/ Medicinal Chemistry pdfLocal anesthetics 2024/ Medicinal Chemistry pdf
Local anesthetics 2024/ Medicinal Chemistry pdf
NarminHamaaminHussen
 
Foundation of Yoga, YCB Level-3, Unit-1
Foundation of Yoga, YCB Level-3, Unit-1 Foundation of Yoga, YCB Level-3, Unit-1
Foundation of Yoga, YCB Level-3, Unit-1
Jyoti Bhaghasra
 
What is Obesity? How to overcome Obesity?
What is Obesity? How to overcome Obesity?What is Obesity? How to overcome Obesity?
What is Obesity? How to overcome Obesity?
Healthmedsrx.com
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
NX Healthcare
 

Recently uploaded (20)

NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
 
Introduction to British pharmacopeia.pptx
Introduction to British pharmacopeia.pptxIntroduction to British pharmacopeia.pptx
Introduction to British pharmacopeia.pptx
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
 
All about shoulder Joint ..
All about shoulder Joint .. All about shoulder Joint ..
All about shoulder Joint ..
 
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticalsacne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
 
Know the difference between Endodontics and Orthodontics.
Know the difference between Endodontics and Orthodontics.Know the difference between Endodontics and Orthodontics.
Know the difference between Endodontics and Orthodontics.
 
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...
 
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Call Girls In Mumbai +91-7426014248 High Profile Call Girl MumbaiCall Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
 
Giloy in Ayurveda - Classical Categorization and Synonyms
Giloy in Ayurveda - Classical Categorization and SynonymsGiloy in Ayurveda - Classical Categorization and Synonyms
Giloy in Ayurveda - Classical Categorization and Synonyms
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
 
RESPIRATORY DISEASES by bhavya kelavadiya
RESPIRATORY DISEASES by bhavya kelavadiyaRESPIRATORY DISEASES by bhavya kelavadiya
RESPIRATORY DISEASES by bhavya kelavadiya
 
Nutritional deficiency disorder in Child
Nutritional deficiency disorder in ChildNutritional deficiency disorder in Child
Nutritional deficiency disorder in Child
 
biomechanics of running. Dr.dhwani.pptx
biomechanics of running.   Dr.dhwani.pptxbiomechanics of running.   Dr.dhwani.pptx
biomechanics of running. Dr.dhwani.pptx
 
pharmacy exam preparation for undergradute students.pptx
pharmacy exam preparation for undergradute students.pptxpharmacy exam preparation for undergradute students.pptx
pharmacy exam preparation for undergradute students.pptx
 
Local anesthetics 2024/ Medicinal Chemistry pdf
Local anesthetics 2024/ Medicinal Chemistry pdfLocal anesthetics 2024/ Medicinal Chemistry pdf
Local anesthetics 2024/ Medicinal Chemistry pdf
 
Foundation of Yoga, YCB Level-3, Unit-1
Foundation of Yoga, YCB Level-3, Unit-1 Foundation of Yoga, YCB Level-3, Unit-1
Foundation of Yoga, YCB Level-3, Unit-1
 
What is Obesity? How to overcome Obesity?
What is Obesity? How to overcome Obesity?What is Obesity? How to overcome Obesity?
What is Obesity? How to overcome Obesity?
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
 

R0 Value & Herd Immunity

  • 1. R0 VALUE & HERD IMMUNITY (HERD EFFECT/ COMMUNITY IMMUNITY/ POPULATION IMMUNITY/ SOCIAL IMMUNITY) DR. BHOJ R SINGH, PRINCIPAL SCIENTIST (VM) HEAD DIVISION OF EPIDEMIOLOGY INDIAN VETERINARY RESEARCH INSTITUTE, IZATNAGAR-243122, BAREILLY, UP, INDIA. TELEFAX +91-581-2302188 THE PROPORTION OF IMMUNE INDIVIDUALS IN A POPULATION ABOVE WHICH A DISEASE MAY NO LONGER PERSIST IS THE HERD IMMUNITY THRESHOLD.
  • 2. R0 VALUES The average number of secondary cases arising from an average primary case in an entirely susceptible population. The basic reproduction number (basic reproductive rate, basic reproductive ratio R0) of a contagious disease is the number of cases than a case of the disease generates (on an average) over the course of its infectious period in a susceptible population.
  • 3. FACTORS DETERMINING THE R0  R0 will vary from agent to agent depending on the infectiousness of the agent.  R0 may also vary from population to population depending on population density.  Course of infectiousness of the disease. Incubation period, latent periods and period of infectiousness).  Mode of transmission and contagiousness.
  • 4. FACTORS AFFECTING R0 It can be explained by the epidemiological triad  Host Factor: Mixed Population, different age group of animals, difference in nutritional status, inbred population, parasitic load and mobility of host.  Environment Factor: Seasonal Variation e.g., FMD (autumn and spring) and Malaria (hot and humid climate).  Agent Factor: The agent may not spread at the same rate in all the countries. Genetic changes in the host factors like Genetic drift and genetic shift. Evolution of new antigenic variant strains.
  • 5. COURSE OF SOME INFECTIOUS DISEASES IN DAYS Infectious disease Incubation period Latent period Infectious period Measles 8-13 6-9 6-7 Mumps 12-26 12-18 4-8 Pertussis 6-10 21-23 7-10 Rubella 14-21 7-14 11-12 Diphtheria 2-5 14-21 2-5 Chickenpox 13-17 8-12 10-11 Hepatitis B 30-80 13-17 19-22 Poliomyelitis 7-12 1-3 14-20 Influenza 1-3 1-3 1-3 Smallpox 10-15 8-11 2-3 Scarlet fever 2-3 1-2 14-21
  • 6. Infectious disease Host R0 Measles Humans (UK) 12-18 Pertussis (whooping cough) Humans (UK) 12-18 Chickenpox (varicella) Humans (UK) 10-12 (16-18 in India) Rubella Humans (UK) 5-7 Smallpox Humans 3.5-7 Feline immunodeficiency virus (FIV) Domestic Cats 1.1-1.5 Rabies Dogs (Kenya) 2.44 Phocine distemper Seals 2-3 Tuberculosis Cattle 2.6 Influenza (Pandemic) Humans 2-4 Foot-and-mouth disease Livestock farms (UK) 3.5-4.5 Mumps Humans 4-12 Poliomyelitis (polio) Humans 5 HIV/AIDS Hetro 2-5 HIV Male homosexuals UK 4 HIV Female prostitutes in Kenya 11 Malaria Humans ≈ 100 SARS Human 2-5 IBR Cattle (UK) 7 TB Cattle 2.6 R0 of Some Diseases
  • 7. R0 IS AFFECTED BY MODE OF TRANSMISSION Disease Transmission R0 Measles Airborne 12–18 Pertussis Airborne droplet 12–17 Diphtheria Saliva 6–7 Smallpox Social contact 5–7 Polio Fecal-oral route 5–7 Rubella Airborne droplet 5–7 Mumps Airborne droplet 4–7 HIV/AIDS Sexual contact 2–5 SARS Airborne droplet 2–5 Influenza (1918 pandemic strain) Airborne droplet 2–3
  • 8. CALCULATION OF R0  R0= β/ γ  γ= 1/ average infectious period  β= Transmission rate (Number contacts by infective case in defined time, contact rate)  If susceptible fraction of a population is >1/R0 then only disease can progress. We can get is by vaccination, preventive therapy or control measures.  When initial fraction of susceptible population is less than γ/β or 1/R0 then infection can not progress and dies out, it is called the threshold fraction.  R0 is also defined as inverse of relative removal rate (the already got infected during the period).  1- 1/R0 is also defined as fraction of the population to be vaccinated for getting herd immunity.
  • 9. HOW TO REDUCE R0 VALUE? R0 can be reduced through intervention at any point in the transmission cycle by the following methods:  Reducing or eliminating the shedding of the agent by the infected host. e.g., by antibiotics and segregation and quarantine.  Reducing the duration of environmental survival of the agent. e.g., sunlight, fumigation, aeration etc.  Reducing or eliminating vehicle contamination and fomite transmission.  Controlling the Vector Population for biological transmission.  Reducing the exposure of susceptible host. e.g., density reduction, provision of protective gears as masks, goggles, aprons, gloves, gumboots etc.  Increasing the resistance of susceptible host by vaccination, passive immunization etc.
  • 10. IMPORTANCE OF RO  For an infectious disease with average infectious period 1/γ and transmission rate β, Ro = β/γ:  For a closed population, an infectious disease can only invade if there is a threshold fraction of susceptible individuals greater than 1/Ro .  If R0 is 2.5 then 1/R0 is 0.4, i.e., for control of the disease less than 0.4 fraction of the population be susceptible or more than 60% be non-susceptible or immune.  Vaccination policy: if proportion of susceptible individuals is reduced to below 1/Ro the disease can be eradicated.
  • 11. LIMITATIONS  When calculated from mathematical models, particularly using ordinary differential equations, R0 is, in fact, simply a threshold, not the average number of secondary infections.  There are many methods used to derive such a threshold from a mathematical model, but many of them often give an hypothetical value sometimes far away from the the true value of R0. This is particularly problematic if there are intermediate vectors between hosts, such as malaria.  Methods include the survival function, rearranging the largest value from the Jacobian matrix, the next-generation method, calculations from the intrinsic growth rate, existence of the endemic equilibrium, the number of susceptibles at the endemic equilibrium, the average age of infection and the final size equation.  Few of these methods agree with one another, even when starting with the same system of differential equations. Even fewer actually calculate the average number of secondary infections. Since R0 is rarely observed in the field and is usually calculated via a mathematical model, this severely limits its usefulness
  • 12. HERD IMMUNITY  The term herd immunity was first used in 1923.  It was an integral part During the Small Pox eradication in the 1960s and 1970s.  The practice of Ring Vaccination, of which herd immunity is integral to, began as a way to immunize every person in a "ring" around an infected individual to prevent outbreaks from spreading.  Vaccination controversies and opposing of vaccination are mainly due to failed herd immunity, either it was not be established or disappeared in certain communities, allowing preventable diseases to persist in or return to these communities.  Topley, W. W. C.; Wilson, G. S. (May 1923). "The Spread of Bacterial Infection. The Problem of Herd- Immunity". The Journal of Hygiene (London). 21 (3): 243– 249. PMC 2167341 . PMID 20474777. doi:10.1017/s0022172400031478.  Strassburg, M. A. (1982). "The global eradication of smallpox". American journal of infection control. 10 (2): 53– 9. PMID 7044193. doi:10.1016/0196-6553(82)90003-7.
  • 13. DEFINITION OF HERD IMMUNITY As per John TJ, Samuel R. European Journal of Epidemiology 2000;16, Herd Immunity can be defined as follows: 1. The resistance of a group for attack by a disease because of the immunity of a large proportion of the members and the consequent lessening of the likelihood of an affected individual coming into contact with a susceptible individual. 2. The prevalence of immunity in a population above which it becomes difficult for the organism to circulate and reach new susceptible is called herd immunity. 3. It is well known that not everyone in a population needs to be immunised to eliminate disease.
  • 14. HERD IMMUNITY  The indirect protection from infection of susceptible livestock in a herd, and the protection of the herd as a whole, which is brought about by the presence of immune individuals.  The number of individuals in a population (herd) who are (relatively) immune to infection with an infectious agent may depend on the proportion who have previously been infected with the agent and the proportion who have been vaccinated with an efficacious vaccine.
  • 15.
  • 16.  A measure of the level of population-immunity or herd- immunity is the proportion who are thus immune from further infection.  For many infections, the level of herd immunity may have an effect on the transmission of the infection within the population and, in particular, may affect the risk of an uninfected becoming infected.  For such infections, increasing the level of herd immunity will decrease the risk of an uninfected person becoming infected.  If the herd effect reduces the risk of infection among the uninfected sufficiently then the infection may no longer be sustainable within the population and the infection may be eliminated.  This concept is important in disease elimination or eradication programmes. It means, for example, that elimination can be achieved without necessarily vaccinating the entire population.
  • 17. TYPES OF HERD IMMUNITY Innate (Inherent) Herd Immunity: It is genetically determined physiological changes with respect to antibody production or other defence mechanism in a herd. It does not depend on the previous exposure of herd with infection or it may arise in a herd through prolonged exposure to an infection or natural selection.
  • 18.  Some population of domestic fowl have innate resistance to pullorum disease due to an inherited difference in lymphocyte numbers immediately after hatching.(Robert & Card,1926)  Inheritance of resistance to influenza virus in mice is probably due to a single dominant autosomal allele. (Lindermann, 1964)  Cameroon et al have shown that resistance to brucellosis in swine may be genetically determined.
  • 19. Acquired Herd Immunity: It is a type of herd immunity where a sufficient number of its members have actually been exposed naturally or artificially to infectious agents during their lifespan.  This kind of exposure may be made very early in life.  Polio in paralytic form are rare in countries with poor hygiene and sanitation where exposure to the virus occurs in early part of life but in countries where the hygiene is better and exposure is delayed till school age then paralytic manifestations are higher.
  • 20.
  • 21.
  • 22.
  • 23.
  • 24.
  • 25.
  • 26.
  • 27. ADVANTAGES OF HERD IMMUNITY  Potential for infection elimination.  Reduced risk of infection for those refusing vaccination (“free riders”).  Vaccination against sexually transmitted diseases (STIs) targeted at one sex result in significant declines in sexual disease in both sexes.  Reduced risk of infection for those for whom vaccination is contraindicated (e.g., immune-suppressed) or who cannot be vaccinated e.g., cancer patients, too young animals and pregnant animals.  Prioritization of vaccination towards target groups or High Risk groups in the community may lead to protection of the whole community e.g. prioritization of vaccinating children against pneumococcus and rotavirus, school-age children for seasonal flu immunization reduces of the disease burden in the whole community.
  • 28. Limitations  Herd immunity generally applies only to diseases that are contagious. It does not apply to diseases such as tetanus, botulism food borne infections and intoxications.  Raise the average age of infection among those who are infected.  Particular problem for those infections where the severity of infection increases with age (e.g. polio, rubella, varicella, measles, hepatitis A).  It is not a permanent attribute, depending on the duration of the immunity conferred after vaccination the structure of herd for susceptible versus immune rapidly changes.  Herd immunity might be associated with emergence of variants of pathogens more dangerous than the existent due to Evolution Pressure on the pathogen or Selection Pressure on the antigen variant.  Herd immunity may lead to antigenic variation among pathogens at much faster rate than it would have been in the absence of herd immunity. Leading to Serotype Replacement.  Herd immunity not work for many of the infectious diseases like Tetanus, Botulism, and similar toxico-infections.
  • 29. BACTERIAL DISEASES OF LIVESTOCK Sl. No Name of the Disease Host Range Type of Vaccine Used Duration of Immunity 1 Haemorrhagic Septicemia Cattle, Sheep & Goat, Pig Inactivated alum adjuvant vaccine 6 months 2 Black Quarter Cattle, Sheep & Goat Inactivated alum adjuvant vaccine 6 months 3 Anthrax Cattle, Sheep & Goat Sterne-avirulent spore vaccine 1 year 4 Brucellosis Cattle, Sheep & Goat Live freeze dried vaccine Life Long 5 Enterotoxemia Sheep Inactivated alum adjuvant vaccine 6 months 6 Leptospirosis Canine Killed Mixed Vaccine 1 year
  • 30. DISEASE ELIMINATION & HERD IMMUNITY  If the herd effect reduces the risk of infection among the uninfected sufficiently then the infection may no longer be sustainable within the population and the infection may be eliminated.  The “effective reproduction number” (R) has to be reduced below 1.  If a proportion (P) of the population are immune then R = (1- P) R0 So, to get R down to about 1, P must be more than 1-1/ R0. Thus if R0 = 5 then vaccine coverage will have to be in excess of 80%.
  • 31. QUIZ  What are the factors affecting reproduction ratio (R0 ) of a disease?  Give R0 values for important animal diseases.  How is associated with herd immunity?  Give herd immunity values required for prevention of FMD, HS, BQ, Enterotoxemia, Goat Pox, Sheep Pox, PPR, Brucellosis, Classical swine fever.  What are different types of herd immunity in animals?  An useful link https://www.historyofvaccines.org/content/herd- immunity-0